Imugene Ltd
ASX:IMU

Watchlist Manager

Imugene Ltd

ASX:IMU

Watchlist

Dividends

Price: 0.41 AUD -3.53%

Market Cap: 3.1B AUD

Have any thoughts about
Imugene Ltd?

Write Note

Write Note Create Alert Ask AI

Add Note Why Create Notes?

Capture your thoughts

Note Buy Sell Hold Pass

US	Johnson & Johnson NYSE:JNJ	Pharmaceuticals
US	Berkshire Hathaway Inc NYSE:BRK.A	Financial Services
US	Bank of America Corp NYSE:BAC	Banking
US	Mastercard Inc NYSE:MA	Technology
US	UnitedHealth Group Inc NYSE:UNH	Health Care
US	Exxon Mobil Corp NYSE:XOM	Energy
US	Pfizer Inc NYSE:PFE	Pharmaceuticals
US	Palantir Technologies Inc NYSE:PLTR	Technology
US	Nike Inc NYSE:NKE	Textiles, Apparel & Luxury Goods
US	Visa Inc NYSE:V	Technology
CN	Alibaba Group Holding Ltd NYSE:BABA	Retail
US	JPMorgan Chase & Co NYSE:JPM	Banking
US	Coca-Cola Co NYSE:KO	Beverages
US	Walmart Inc NYSE:WMT	Retail
US	Verizon Communications Inc NYSE:VZ	Telecommunication
US	Chevron Corp NYSE:CVX	Energy

Add Price Alert

Price Target:

Last Price: 0.41 AUD

We'll email you a reminder when the closing price reaches USD.

If you don’t study any companies, you have the same success buying stocks as you do in a poker game if you bet without looking at your cards.

Peter Lynch

Track and Analyze Performance

Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.

Continuous Learning and Adaptation

Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.

Boost Decision Confidence

With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.

Why create notes?

Back

Delete Note

Do you really want to delete this note?
This action cannot be undone.

Remove price alert for reaching false

Delete

Cancel

IMU Alert

Imugene Ltd

0.41

-0.015 (-3.53%)

52 Week Range	0.011 0.476
Price Target

We'll email you a reminder when the closing price reaches AUD.

Save Alert

Choose the stock you wish to monitor with a price alert.

	Johnson & Johnson NYSE:JNJ	US
	Berkshire Hathaway Inc NYSE:BRK.A	US
	Bank of America Corp NYSE:BAC	US
	Mastercard Inc NYSE:MA	US
	UnitedHealth Group Inc NYSE:UNH	US
	Exxon Mobil Corp NYSE:XOM	US
	Pfizer Inc NYSE:PFE	US
	Palantir Technologies Inc NYSE:PLTR	US
	Nike Inc NYSE:NKE	US
	Visa Inc NYSE:V	US
	Alibaba Group Holding Ltd NYSE:BABA	CN
	JPMorgan Chase & Co NYSE:JPM	US
	Coca-Cola Co NYSE:KO	US
	Walmart Inc NYSE:WMT	US
	Verizon Communications Inc NYSE:VZ	US
	Chevron Corp NYSE:CVX	US

Delete Alert

This alert will be permanently deleted.

Remove note

Delete

Cancel

Ask me anything about

Imugene Ltd

What unique competitive advantages
does Imugene Ltd hold over its rivals?

What risks and challenges
does Imugene Ltd face in the near future?

Provide an overview of the primary business activities
of Imugene Ltd.

Show me price targets
for Imugene Ltd made by professional analysts.

Provide an overview of the primary business activities
of Imugene Ltd.

What unique competitive advantages
does Imugene Ltd hold over its rivals?

What risks and challenges
does Imugene Ltd face in the near future?

Has there been any significant insider trading activity
in Imugene Ltd recently?

Show all valuation multiples
for Imugene Ltd.

Provide P/S
for Imugene Ltd.

Provide P/E
for Imugene Ltd.

Provide P/OCF
for Imugene Ltd.

Provide P/FCFE
for Imugene Ltd.

Provide P/B
for Imugene Ltd.

Provide EV/S
for Imugene Ltd.

Provide EV/GP
for Imugene Ltd.

Provide EV/EBITDA
for Imugene Ltd.

Provide EV/EBIT
for Imugene Ltd.

Provide EV/OCF
for Imugene Ltd.

Provide EV/FCFF
for Imugene Ltd.

Provide EV/IC
for Imugene Ltd.

Show me price targets
for Imugene Ltd made by professional analysts.

What are the Revenue projections
for Imugene Ltd?

How accurate were the past Revenue estimates
for Imugene Ltd?

What are the Net Income projections
for Imugene Ltd?

How accurate were the past Net Income estimates
for Imugene Ltd?

What are the EPS projections
for Imugene Ltd?

How accurate were the past EPS estimates
for Imugene Ltd?

What are the EBIT projections
for Imugene Ltd?

How accurate were the past EBIT estimates
for Imugene Ltd?

Compare the revenue forecasts
for Imugene Ltd with those of its competitors based on recent analyst estimates.

Compare the intrinsic valuations
of Imugene Ltd and its key competitors using the latest financial data.

Compare historical revenue growth rates
of Imugene Ltd against its competitors.

Analyze the profit margins
(gross, operating, and net) of Imugene Ltd compared to its peers.

Compare the P/E ratios
of Imugene Ltd against its peers.

Discuss the investment returns and shareholder value creation
comparing Imugene Ltd with its peers.

Analyze the financial leverage
of Imugene Ltd compared to its main competitors.

Show all profitability ratios
for Imugene Ltd.

Provide ROE
for Imugene Ltd.

Provide ROA
for Imugene Ltd.

Provide ROIC
for Imugene Ltd.

Provide ROCE
for Imugene Ltd.

Provide Gross Margin
for Imugene Ltd.

Provide Operating Margin
for Imugene Ltd.

Provide Net Margin
for Imugene Ltd.

Provide FCF Margin
for Imugene Ltd.

Show all solvency ratios
for Imugene Ltd.

Provide D/E Ratio
for Imugene Ltd.

Provide D/A Ratio
for Imugene Ltd.

Provide Interest Coverage Ratio
for Imugene Ltd.

Provide Altman Z-Score Ratio
for Imugene Ltd.

Provide Quick Ratio
for Imugene Ltd.

Provide Current Ratio
for Imugene Ltd.

Provide Cash Ratio
for Imugene Ltd.

What is the historical Revenue growth
over the last 5 years for Imugene Ltd?

What is the historical Net Income growth
over the last 5 years for Imugene Ltd?

What is the current Free Cash Flow
of Imugene Ltd?

Discuss the annual earnings per share (EPS)
trend over the past five years for Imugene Ltd.

Wall Street Price Targets Revenue Forecast Operating Income Forecast Net Income Forecast See Also

Section:

Wall Street Price Targets

Revenue Forecast

Operating Income Forecast

Net Income Forecast

Wall Street
Price Targets

IMU Price Targets Summary
Imugene Ltd

Wall Street analysts forecast IMU stock price to drop over the next 12 months.

According to Wall Street analysts, the average 1-year price target for IMU is 0.26 AUD with a low forecast of 0.1 AUD and a high forecast of 0.42 AUD.

Lowest

Price Target

0.1 AUD

75% Downside

Average

Price Target

0.26 AUD

38% Downside

Highest

Price Target

0.42 AUD

2% Upside

Imugene Ltd Competitors:
Price Targets

NRIX

Nurix Therapeutics Inc

150% Upside

251120

Bio-FD&C Co Ltd

0% Upside

688105

Nanjing Vazyme Biotech Co Ltd

11% Upside

ELDN

Eledon Pharmaceuticals Inc

195% Upside

NRIX

Nurix Therapeutics Inc

150% Upside

251120

Bio-FD&C Co Ltd

0% Upside

688105

Nanjing Vazyme Biotech Co Ltd

11% Upside

ELDN

Eledon Pharmaceuticals Inc

195% Upside

STOK

Stoke Therapeutics Inc

95% Upside

AGIO

Agios Pharmaceuticals Inc

56% Upside

002252

Shanghai RAAS Blood Products Co Ltd

6% Upside

VTGN

VistaGen Therapeutics Inc

500% Upside

Revenue
Forecast

Revenue Estimate
Imugene Ltd

N/A

Past Growth

N/A

Estimated Growth

N/A

Estimates Accuracy

N/A

Average

What are analyst estimates?

Operating Income
Forecast

Operating Income Estimate
Imugene Ltd

N/A

Past Growth

N/A

Estimated Growth

Estimates Accuracy

Average Beat

What are analyst estimates?

Net Income
Forecast

Net Income Estimate
Imugene Ltd

N/A

Past Growth

N/A

Estimated Growth

Estimates Accuracy

-31%

Average Miss

What are analyst estimates?

What is IMU's stock price target?

Price Target
0.26 AUD

According to Wall Street analysts, the average 1-year price target for IMU is 0.26 AUD with a low forecast of 0.1 AUD and a high forecast of 0.42 AUD.

	Franklin Covey Co NYSE:FC	21.28 USD -3.71%
	Mohawk Industries Inc NYSE:MHK	107.23 USD -3.26%
	Ardmore Shipping Corp NYSE:ASC	10.4 USD 1.46%
	ASGN Inc NYSE:ASGN	49.56 USD -6.21%
	Skyworks Solutions Inc NASDAQ:SWKS	76.19 USD -3.26%
	Weatherford International PLC NASDAQ:WFRD	52.94 USD -2.23%

	Johnson & Johnson NYSE:JNJ	155.27 USD -0.47%
	Bank of America Corp NYSE:BAC	48.66 USD -0.55%
	Mastercard Inc NYSE:MA	565.12 USD -0.72%
	Salesforce Inc NYSE:CRM	269.8 USD -0.86%
	Abbvie Inc NYSE:ABBV	187.63 USD -0.87%
	Home Depot Inc NYSE:HD	367.64 USD -1.09%

	Monolithic Power Systems Inc NASDAQ:MPWR	741.17 USD -2.3%
	NVIDIA Corp NASDAQ:NVDA	158.24 USD -0.69%
	Pro Medicus Ltd ASX:PME	314.96 AUD 1.61%
P	Plover Bay Technologies Ltd HKEX:1523	6.03 HKD -0.5%
S	SciClone Pharmaceuticals (Holdings) Ltd HKEX:6600	18.72 HKD
	Alfa Financial Software Holdings PLC LSE:ALFA	220.5 GBX -0.45%

	Salesforce Inc NYSE:CRM	269.8 USD -0.86%
	Accenture PLC NYSE:ACN	300.54 USD -1.39%
	ServiceNow Inc NYSE:NOW	1 035.01 USD -0.93%
	Spotify Technology SA NYSE:SPOT	736.29 USD 1.55%
	EOG Resources Inc NYSE:EOG	119.61 USD -2.87%
	Monster Beverage Corp NASDAQ:MNST	62.85 USD -0.36%

Imugene Ltd
ASX:IMU